Mastering the Lateral Flow Assay (LFA): Techniques, Challenges, and Solutions

Lateral Flow Assays (LFAs) have become the backbone of rapid diagnostics, from pregnancy tests to infectious disease detection. Yet, one recurring challenge haunts manufacturers and researchers alike: sensitivity. A strip may look perfect, but if its limit of detection is too high or results are inconsistent, the kit fails both regulators and end-users.

At Prahas Healthcare, we’ve worked closely with global IVD companies and identified the key culprits behind low sensitivity — and, more importantly, the solutions.

The Sensitivity Problem in LFA

– Low-affinity antibodies → weak binding, faint lines
– Unstable conjugates → gold nanoparticle aggregation, poor visibility
– Poor-quality pads → uneven flow, incomplete reaction
– Manual dispensing → line inconsistency and lot-to-lot variation

The result? False negatives, poor reproducibility, and loss of trust in diagnostic performance.

Solutions

1. High-Affinity Monoclonal Antibodies – strong binding, reduced cross-reactivity, consistent results.
2. Conjugate Pads + Stabilizers – prevent aggregation, control release, extend shelf life.
3. Automation for Precision – reel-to-reel dispensing, rotary slitters, vision inspection.

Watch our automation in action: https://www.youtube.com/@prahashealthcarellp7282/videos

Case Example

A diagnostic company in Southeast Asia switched to Prahas antibodies + conjugate stabilizers. Combined with our automated dispensing system, they achieved 40% lower detection limits, 25% longer shelf life in 35°C storage, and fewer rejected batches.

Conclusion

Improving sensitivity isn’t about a single product — it’s about a complete solution. At Prahas Healthcare, we provide end-to-end support for LFA manufacturers.

Contact us today: +91 9824704223  
Email: sales.exec@prahashealthcare.com | hasnain@prahashealthcare.com  
Website: www.prahashealthcare.com